The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
Open accessAbstract
OBJECTIVE: Activated microglia are thought to play a major role in cortical gray matter (GM) demyelination in multiple sclerosis (MS). Our objective was to evaluate microglial activation in cortical GM of patients with MS in vivo and to explore its relationship to measures of disability. METHODS: Using PET and optimized modeling and segmentation procedures, we investigated cortical (11)C-PK11195 (PK11195) binding in patients with relapsing-remitting MS (RRMS), patients with secondary progressive MS (SPMS), and healthy controls. Disability was assessed with the Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Impact Scale (MSIS-29). RESULTS: Patients with MS showed increased cortical GM PK11195 binding relative to controls, which was multifocal and highest in the postcentral, middle frontal, anterior orbital, fusiform, and parahippocampal gyri. Patients with SPMS also showed additional increases in precentral, superior parietal, lingual and anterior superior, medial and inferior temporal gyri. Total cortical GM PK11195 binding correlated with EDSS scores, with a stronger correlation for the subgroup of patients with SPMS. In patients with SPMS, PK11195 binding also correlated with MSIS-29 scores. No correlation with disability measures was seen for PK11195 binding in white matter. Higher EDSS scores correlated with higher levels of GM PK11195 binding in the postcentral gyrus for patients with RRMS and in precentral gyrus for those with SPMS. CONCLUSIONS: Microglial activation in cortical GM of patients with MS can be assessed in vivo. The distribution is not uniform and shows a relationship to clinical disability. We speculate that the increased PK11195 binding corresponds to enhanced microglial activation described in postmortem SPMS cortical GM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While populations of patients undoubtedly show heterogeneity of grey matter pathology, our observations here raise questions about the interpretation of widespread TSPO PET signal in the cortical region as arising from cortical lesions (Politis et al., 2012), as opposed to meningeal (Howell et al., 2011) or leukocortical inflammation.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Politis et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Magliozzi, R., Howell, O. W., Vora, A., Serafini, B., Nicholas, R. S., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,492
Self-citationPeterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Hammers, A., Allom, R. J., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,270
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
The CAMMS Trial Investigators (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802670 · Cited by 1,021
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J. W., Chang, A., Torres, T., Gudz, T. I., Macklin, W. B., Lewis, D., Fox, R., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 881
Cited by
Sorted by citations
Items 101–177 of 177
Targeting PKC in microglia to promote remyelination and repair in the CNS
Kim, P. M., & Kornberg, M. D. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.008 · Cited by 25
Hojjat, S., Cantrell, C. G., Carroll, T., Vitorino, R., Feinstein, A., Zhang, L., Symons, S. P., Morrow, S. A., Lee, L., O'Connor, P. W., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516628656 · Cited by 25
Misin, O., Matilainen, M., Nylund, M., Honkonen, E., Rissanen, E., Sucksdorff, M., & Airas, L. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001182 · Cited by 24
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis
Herranz, E., Treaba, C. A., Barletta, V. T., Mehndiratta, A., Ouellette, R., Sloane, J. A., Ionete, C., Babu, S., Mastantuono, M., Magon, S., et al. (2024) · Brain · doi:10.1093/brain/awae030 · Cited by 22
Self-citationExploring the role of microglia in mood disorders associated with experimental multiple sclerosis
Gentile, A., Vito, F. D., Fresegna, D., Musella, A., Buttari, F., Bullitta, S., Mandolesi, G., & Centonze, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00243 · Cited by 22
Elo, P., Li, X., Liljenbäck, H., Helin, S., Teuho, J., Koskensalo, K., Saunavaara, V., Marjamäki, P., Oikonen, V., Virta, J., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1612-3 · Cited by 21
Faria, D. D. P., Vlaming, M. L. H., Copray, S. C. V. M., Tielen, F. J., Anthonijsz, H. J. A., Sijbesma, J. W. A., Buchpiguel, C. A., Dierckx, R., van der Hoorn, J. W. A., & de Vries, E. F. J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.137216 · Cited by 21
Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use
George, N., Gean, E. G., Nandi, A., Фролов, Б. А., Zaidi, E., Lee, H., Brašić, J. R., & Wong, D. F. (2015) · CNS Drugs · doi:10.1007/s40263-015-0237-z · Cited by 21
Filippi, M., Preziosa, P., & Rocca, M. A. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00020-9 · Cited by 21
Advanced imaging tools to investigate multiple sclerosis pathology
Bodini, B., Louapre, C., & Stankoff, B. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.02.011 · Cited by 18
TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis
Weiner, H. L., Bakshi, R., & Singhal, T. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608715 · Cited by 18
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
Contentti, E. C., & Correale, J. D. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s348129 · Cited by 18
Glial cells as therapeutic targets in progressive multiple sclerosis
Wilbanks, B., Maher, L., & Rodriguez, M. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1614443 · Cited by 17
Saraste, M., Matilainen, M., Rajda, C., Galla, Z., Sucksdorff, M., Vécsei, L., & Airas, L. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103667 · Cited by 19
Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study
Pitombeira, M. S., Koole, M. J. B., Campanholo, K. R., de Souza, A. B. P., Duran, F., Solla, D. J. F., Mendes, M. F., Apóstolos‐Pereira, S. L., Rimkus, C. D. M., Busatto, G. F., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05899-2 · Cited by 20
Lehto, J., Nylund, M., Matilainen, M., Sucksdorff, M., Vuorimaa, A., Rajander, J., Wahlroos, S., Hariri, P., & Airas, L. M. (2023) · European Journal of Neurology · doi:10.1111/ene.15834 · Cited by 18
Longitudinal change in TSPO PET imaging in progressive multiple sclerosis
Kang, Y., Pandya, S., Zinger, N., Michaelson, N., & Gauthier, S. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51431 · Cited by 15
Lopresti, B. J., Royse, S. K., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15615 · Cited by 16
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
Raval, N. R., Wetherill, R. R., Wiers, C. E., Dubroff, J. G., & Hillmer, A. T. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.08.008 · Cited by 15
Linking Cognitive Impairment to Neuroinflammation in Multiple Sclerosis using neuroimaging tools
Barros, C., & Fernandes, A. M. A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102622 · Cited by 15
Special issue commentary: The changing face of inflammation in the brain
Anthony, D. C., & Pitossi, F. J. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.005 · Cited by 15
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous SystemPreprint
Kornberg, M. D., & Calabresi, P. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041374 · Cited by 17
Singhal, T., Cicero, S., Rissanen, E., Ficke, J., Kukreja, P., Vaquerano, S., Glanz, B. I., Dubey, S., Sticka, W., Seaver, K., et al. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005201 · Cited by 11
Microglia and Multiple Sclerosis
Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11
Biomarkers in multiple sclerosis: an update for 2014.
Fernández, Ó., Martinꝉ, R., Rovira, À., Llufriú, S., Vidal‐Jordana, Á., Fernández-Sánchez, V. E., Alvarez-Cermeño, J. C., Izquierdo, G., Arroyo-González, R., Antigüedad, A. R., et al. (2014) · PubMed · Cited by 11
Kang, Y., Rúa, S., Kaunzner, U., Perumal, J., Nealon, N., Qu, W.-C., Kothari, P., Vartanian, T., Kuceyeski, A., & Gauthier, S. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01501-z · Cited by 9
Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis.
Laaksonen, S., Saraste, M., Sucksdorff, M., Nylund, M., Vuorimaa, A., Matilainen, M., Heikkinen, J., & Airas, L. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104755 · Cited by 10
Microglia positron emission tomography and progression in multiple sclerosis: thalamus on fire
Zeydan, B., Neyal, N., Son, J., Schwarz, C. G., Thomas, J. C. K., Morrison, H. A., Bush, M. L., Reid, R. I., Przybelski, S. A., Fought, A. J., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf141 · Cited by 10
Spring cleaning: time to rethink imaging research lines in MS?
Absinta, M., Reich, D. S., & Filippi, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8060-0 · Cited by 10
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – Yes
van Wageningen, T. A., & van Dam, A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517739139 · Cited by 9
Advanced Brain Imaging in Central Nervous System Demyelinating Diseases
Cagol, A., Tsagkas, C., & Granziera, C. (2024) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.03.003 · Cited by 8
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
Har-Shalom, I., Karni, A., & Kolb, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010474 · Cited by 9
Non-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7
García, D. V., Doorduin, J., Faria, D. D. P., Dierckx, R., & de Vries, E. D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9741-x · Cited by 6
Advances in Imaging Multiple Sclerosis
Caverzasi, E., Cordano, C., Hauser, S. L., Henry, R. G., & Bischof, A. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1607278 · Cited by 6
Herranz, E., Hooker, J. M., Izquierdo-García, D., Loggia, M., & Mainero, C. (2017) · Annals of Neurology · doi:10.1002/ana.24865 · Cited by 1
Ghafoor, D. D., Ahmad, D. O., Najmuldeen, H. H. R., Mohammed, S. J., Jalal, P. J., Mustafa, F. S., Alghofaili, F., Zangana, B. A., & Al-Bajalan, S. J. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02012-5 · Cited by 5
Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression
Corazzolla, G., Treaba, C. A., Mohammadian, M., Brusaferri, L., Barletta, V. T., Zürcher, N. R., Hooker, J. M., Sloane, J. A., Klawiter, E. C., Bomprezzi, R., et al. (2026) · Brain · doi:10.1093/brain/awag084 · Cited by 5
Liu, X., Wang, Y., Wei, N., Zhu, W., Suo, Y., Xu, Y., Jin, A., Xu, Q., Qi, N., Jiang, Q., et al. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251328902 · Cited by 5
Lus, G., Bassano, M. A., Morra, V. B., Bonavita, S., Gallo, A., Maimone, D., Malerba, L., Maniscalco, G. T., Saccà, F., Salemi, G., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06402-3 · Cited by 5
Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment
Kim, J., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_14 · Cited by 3
Tozlu, C., Jamison, K. W., Kang, Y., Rúa, S. M. H., Kaunzner, U. W., Nguyen, T., Kuceyeski, A. F., & Gauthier, D. S. A. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1107 · Cited by 4
Statsenko, Y., Smetanina, D., Arora, T., Östlundh, L., Habuza, T., Simiyu, G., Meribout, S., Talako, T., King, F. C., Makhnevych, I., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068608 · Cited by 2
PET Imaging in Multiple Sclerosis
van der Weijden, C. W. J., Meilof, J. F., & de Vries, E. F. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_33 · Cited by 4
PET Imaging of Translocator Protein Expression in Neurological Disorders
Brooks, D. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_30 · Cited by 4
Assessment of 18F-PBR-111 in the Cuprizone Mouse Model of Multiple Sclerosis
Jewells, V. L., Yuan, H., Merrill, J. R., Frank, J. E., Patel, A., Cohen, S. M., Giglio, B. C., Feinberg, N. N., Matsushima, G. K., & Li, Z. (2021) · Diagnostics · doi:10.3390/diagnostics11050786 · Cited by 4
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Calabresi, P. A., & Bohnen, N. I. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635824 · Cited by 3
Tang, S., Harrison, D. M., Bardhoshi, A., Cureton, R., Yan, X., Parcon, P. A., Morse, C. L., Ecker, C., Choi, S., Pike, V. W., et al. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251332490 · Cited by 2
PET Imaging in Multiple Sclerosis: Focus on the Translocator Protein
Colasanti, A., & Piccini, P. P. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_35 · Cited by 2
Self-citationPET Imaging of Translocator Protein Expression in Neurological Disorders
Brooks, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_22 · Cited by 2
Semiquantification Study of [11C]-(R)-PK11195 PET Brain Images in Multiple Sclerosis
Narciso, L., Schuck, P. N., Dartora, C. M., Matushita, C. S., Becker, J., & da Silva, A. M. M. (2016) · Revista Brasileira de Física Médica · doi:10.29384/rbfm.2016.v10.n2.p39-43 · Cited by 2
Huang, J., Li, Q., & Lu, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-9902-4_16 · Cited by 1
Mantovani, D. B. A., Pitombeira, M., Schuck, P., de Araújo, A. S., Buchpiguel, C., Faria, D. D. P., & da Silva, A. D. (2024) · Journal of Imaging · doi:10.3390/jimaging10020039 · Cited by 1
PET Imaging of Microglia Activation in Neuropsychiatric Disorders with Potential Infectious Origin
Klein, H. C., de Witte, L. D., Bransfield, R. C., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_34 · Cited by 1
Surrogate Markers in Multiple Sclerosis
Rocca, M. A., Comı, G., & Filippi, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00015-5 · Cited by 2
Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials – YES
Kapoor, R. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517713344 · Cited by 1
Myeloid Cells in Multiple Sclerosis
Wang, M., Caryotakis, S. E., Kumar, N., Nguyen, A. V., & Soulika, A. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86285 · Cited by 2
Klein, H. C., de Witte, L. D., Bransfield, R. C., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_32 · Cited by 1
Neuroimaging in multiple system atrophy
Tondo, G., Comi, C., Naldi, A., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00008-7 · Cited by 1
Self-citationBlood-Brain Barrier Permeability and Inflammation in Cerebral Small Vessel Disease
Walsh, J. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.50869 · Cited by 2
Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione
Knezevic, D. (2016) · TSpace (University of Toronto)
Geração de Imagens PET Estáticas com [11C]-(R)-PK11195: Definição do Intervalo Temporal
Schuck, P. N., Dartora, C. M., & da Silva, A. M. M. (2017) · Revista Brasileira de Física Médica · doi:10.29384/rbfm.2017.v11.n2.p25-29
Bezukladova, S. (2018) · Doria (University of Helsinki)
Colasanti, A. (2014) · Spiral (Imperial College London) · doi:10.25560/25285
Activation of cortical microglia linked to level of disability in patients with multiple sclerosis
(2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.152
Nuclear Imaging of Inflammation
Keeling, G. P., & Man, F. (2023) · Progress in inflammation research · doi:10.1007/978-3-031-23661-7_2
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00006-x
Functional Neuroradiology of Multiple Sclerosis: Non-BOLD Techniques
Pizzini, F. B., & Talenti, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_15
Imagem PET de processos relacionados à esclerose múltipla: estudo clínico
Pitombeira, M. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-20042023-115057
Singhal, T., Cicero, S., Rissanen, E., Ficke, J., Kukreja, P., Vaquerano, S., Glanz, B. I., Dubey, S., Sticka, W., Seaver, K., et al. (2023) · medRxiv · doi:10.1101/2023.10.06.23295721
Lysophosphatidic acid receptor 1 influences disease severity in a mouse model of multiple sclerosisPreprint
Uemura, N., Matsuo, N., Taniyama, K., Nakajima, H., Nagayasu, K., Kaneko, S., Chun, J. J. M., Ueda, H., & Shirakawa, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596148
Ezzat, D., Haest, S., Hertogs, S., Kalemkus, E., Leroi‐Werelds, S., & Hellings, N. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106177
Positron emission tomography imaging in multiple sclerosis
Cicero, S., Hansel, C., Rissanen, E., & Singhal, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00019-8
Along-tract and across-plexus propagation of tissue damage in multiple sclerosis
Ricigliano, V. A. G. (2021) · theses.fr (ABES) · doi:10.70675/d9e05903zbf45z4f3cz9290z50f80f3e4ead
Vavasour, I. M., Vafai, N. M., Beauchemin, P., Shahinfard, E., Laule, C., Traboulsee, A. L., Sossi, V., Kolind, S., & Carruthers, R. L. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107189
Metadata
- Authors
- Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Malik, O., Matthews, P. M., Reynolds, R., Nicholas, R., & Piccini, P.
- Affiliations
- Hammersmith Hospital (GB)
- From the Centre for Neuroscience (M.P., P.G., P.S., F.T., K.W., A.W., P.M.M., R.R., R.N., P.P.), Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London; Clinical Sciences Center, Medical Research Council (M.P., P.G., P.S., F.T., S.K., K.W., A.W., P.P.), and GSK Clinical Imaging Centre (P.M.M.), Hammersmith Hospital, London; Dementia Research Centre (S.K.), UCL Institute of Neurology, London; and Department of Clinical Neurosciences (O.M., R.N.),...
- ORCID
- Venue
- Neurology
- Published
- 2012-08-07
- Volume
- 79
- Issue
- 6
- Pages
- 523-530
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3413767
- OpenAlex
- W2148602027
- Cited by
- 176
- References
- 41
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 9 · 2019: 15 · 2018: 13 · 2017: 15 · 2016: 19 · 2015: 21 · 2014: 19 · 2013: 7 · 2012: 5
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- multiple sclerosis, microglial activation, PK11195, [11C]PK11195 PET, cortical gray matter, disability, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, demyelination, Expanded Disability Status Scale, MSIS-29, postcentral gyrus, precentral gyrus
- MeSH terms
- Adult, Cerebral Cortex, Female, Humans, Isoquinolines, Male, Middle Aged, Multiple Sclerosis, Microglia, Radiopharmaceuticals, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
